NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $432,599 | +0.9% | 4,247 | 0.0% | 0.04% | 0.0% |
| Q2 2023 | $428,565 | -14.5% | 4,247 | -22.0% | 0.04% | -20.4% |
| Q1 2023 | $501,124 | +1.4% | 5,447 | 0.0% | 0.05% | -3.6% |
| Q4 2022 | $494,152 | +22.0% | 5,447 | +2.3% | 0.06% | +47.4% |
| Q3 2022 | $405,000 | -10.0% | 5,322 | 0.0% | 0.04% | -29.6% |
| Q2 2022 | $450,000 | -15.3% | 5,322 | -12.1% | 0.05% | -3.6% |
| Q1 2022 | $531,000 | +0.4% | 6,052 | 0.0% | 0.06% | 0.0% |
| Q4 2021 | $529,000 | +6.9% | 6,052 | 0.0% | 0.06% | -1.8% |
| Q3 2021 | $495,000 | -20.3% | 6,052 | -11.1% | 0.06% | -19.7% |
| Q2 2021 | $621,000 | -9.2% | 6,806 | -15.0% | 0.07% | -11.2% |
| Q1 2021 | $684,000 | +68.5% | 8,006 | +86.0% | 0.08% | +50.9% |
| Q4 2020 | $406,000 | +782.6% | 4,304 | +726.1% | 0.05% | +278.6% |
| Q2 2020 | $46,000 | – | 521 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |